THE USE OF MEDICINES WITH ANTICHOLINERGIC EFFECTS IN OLDER-PEOPLE - A POPULATION STUDY IN AN URBAN AREA OF SWEDEN

被引:13
作者
FASTBOM, J
CLAESSON, CB
CORNELIUS, C
THORSLUND, M
WINBLAD, B
机构
[1] STOCKHOLM GERONTOL RES CTR,STOCKHOLM,SWEDEN
[2] KAROLINSKA INST,DEPT GERIATR MED,S-10401 STOCKHOLM,SWEDEN
[3] KAROLINSKA HOSP,DEPT CLIN PHARMACOL,S-10401 STOCKHOLM,SWEDEN
[4] UNIV UPPSALA HOSP,DEPT SOCIAL MED,S-75185 UPPSALA,SWEDEN
[5] NATL CORP SWEDISH PHARMACIES,STOCKHOLM,SWEDEN
[6] UNIV STOCKHOLM,DEPT SOCIAL WORK,STOCKHOLM,SWEDEN
关键词
D O I
10.1111/j.1532-5415.1995.tb07015.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVE: To investigate the use of medicines with anticholinergic properties among older people in an urban population in Sweden. DESIGN: A cross-sectional survey. SETTING: Ordinary homes, sheltered accommodations, nursing homes, and geriatric departments. PARTICIPANTS: All residents aged 75 and older in a district of Stockholm, Sweden. MEASUREMENTS: Structured interviews with older persons, their relatives and/or health care personnel; prescription forms; medical records. RESULTS: The overall use of medicines with anticholinergic effects was comparatively low. Doses of these medicines were also generally low. Concurrent use of several such medicines was uncommon. The most prevalent therapeutic/pharmacological group was neuroleptics. In contrast, antidepressants were used by few older people. The prevalence of medicines with anticholinergic effects was highest at institutions, where neuroleptics were frequent and use of low-potency neuroleptics was not uncommon. CONCLUSION: Our results indicate that the risk of anticholinergic side effects may be quite low in the present population as a whole. However, there may be grounds for revising the therapy in institutions, where the use of neuroleptics was shown to be high and low-potency neuroleptics, known to have a higher incidence of anticholinergic side effects, were not avoided.
引用
收藏
页码:1135 / 1140
页数:6
相关论文
共 34 条
[1]  
[Anonymous], 1990, GUIDELINES ATC CLASS
[2]  
Arling G, 1991, J Aging Health, V3, P455, DOI 10.1177/089826439100300402
[3]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[4]   PRESCRIBING OF PSYCHOTROPICS IN ELDERLY NURSING-HOME PATIENTS [J].
BEARDSLEY, RS ;
LARSON, DB ;
BURNS, BJ ;
THOMPSON, JW ;
KAMEROW, DB .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1989, 37 (04) :327-330
[5]  
BERGGREN D, 1987, ANESTH ANALG, V66, P497
[6]  
Blake L M, 1991, Psychiatr Med, V9, P263
[7]   THE RISK OF ANTICHOLINERGIC TOXICITY IN THE ELDERLY - A STUDY OF PRESCRIBING PRACTICES IN 2 POPULATIONS [J].
BLAZER, DG ;
FEDERSPIEL, CF ;
RAY, WA ;
SCHAFFNER, W .
JOURNALS OF GERONTOLOGY, 1983, 38 (01) :31-35
[8]   PSYCHOTROPIC-DRUG PRACTICE IN NURSING-HOMES [J].
BUCK, JA .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1988, 36 (05) :409-418
[9]  
BURNS BJ, 1988, J FAM PRACTICE, V26, P155
[10]   DIFFERENT EFFECTS OF DOPAMINERGIC AND ANTICHOLINERGIC THERAPIES ON COGNITIVE AND MOTOR FUNCTION IN PARKINSONS-DISEASE - A FOLLOW-UP-STUDY OF UNTREATED PATIENTS [J].
COOPER, JA ;
SAGAR, HJ ;
DOHERTY, SM ;
JORDAN, N ;
TIDSWELL, P ;
SULLIVAN, EV .
BRAIN, 1992, 115 :1701-1725